Ori Gutwerg insider trades: Ani Pharmaceuticals (ANIP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ori reports to the SEC
Open-market buys and sales
8 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | ANIP | ↓ Sell | 3,162 | $77.00 | $243K | Direct | Aug 11, 2026 (1d) |
| May 12, 2026 | ANIP | ↓ Sell | 2,772 | $79.50 | $220K | Direct | May 13, 2026 (1d) |
| Mar 3, 2026 | ANIP | ↓ Sell | 2,060 | $76.50 | $158K | Direct | Mar 4, 2026 (1d) |
| Aug 12, 2025 | ANIP | ↓ Sell | 5,873 | $86.53 | $508K | Direct | Aug 14, 2025 (2d) |
| May 15, 2025 | ANIP | ↓ Sell | 881 | $60.07 | $53K | Direct | May 16, 2025 (1d) |
| Mar 5, 2025 | ANIP | ↓ Sell | 5,384 | $60.00 | $323K | Direct | Mar 7, 2025 (2d) |
| Jun 5, 2024 | ANIP | ↓ Sell | 2,985 | $67.00 | $200K | Direct | Jun 6, 2024 (1d) |
| Aug 23, 2023 | ANIP | ↓ Sell | 15,561 | $62.39 | $971K | Direct | Aug 25, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANIP insiders
Open-market trades in the last 12 months
About Ori Gutwerg's insider trades
Ori Gutwerg is SVP, Generics at Ani Pharmaceuticals (ANIP). Since Aug 23, 2023, Ori has reported no open-market purchases and 8 sales worth $2.7M on SEC Form 4. In the last 12 months: 3 sales ($621K).
Their filings also include shares withheld for taxes (12 filings), grants and awards (7 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.
